Logo

American Heart Association

  1
  0


Final ID: WP315

Effects of Alcohol Use on Cerebral Small Vessel Disease and Intracerebral Hemorrhage

Abstract Body: Objective: We sought to investigate the consequences of alcohol intake on intracerebral hemorrhage (ICH) and cerebral small vessel disease (cSVD) in patients with spontaneous ICH.
Methods: We compared markers of cSVD [Figure 1], features of ICH, and outcomes among consecutive spontaneous ICH patients with different alcohol use strata admitted to a tertiary care center between 2003-2019. Alcohol intake was categorized as none/mild (<5 drinks/week), moderate/severe (5 drinks/week-5 drinks/day), and heavy (>5 drinks/day). We performed descriptive statistics and bivariate/multivariate analyses based on demographic and radiologic data.
Results: We included 1590 patients (53% male, median age 74 years [IQR 64-82]). Among them, 82.6% had none/mild alcohol intake, 14.2% moderate/severe, and 3.3% heavy alcohol intake. Heavy alcohol users were 13 years younger at time of ICH than none/mild users (median [IQR], 62 [57-70] vs 75 [65-83], p<0.0001). Heavy alcohol users were more likely to have deep ICHs (60% vs 45%, p=0.037), larger median ICH volumes (30 vs 15mL, p=0.025), and lower platelet counts (195/µL vs 225/µL, p=0.049). MRI analysis showed that heavy alcohol users had similar degree of cSVD as none/mild users, even though they were much younger. In separate regression models heavy alcohol use was independently associated with younger age at the time of ICH (p=0.004) and higher ICH volume (p=0.007). There was no significant difference in in-hospital mortality between the two groups (31% vs 42%, p=0.1).
The moderate/severe users were 5 years younger at the time of ICH compared to none/mild alcohol users (p<0.0001). There was no significant difference in ICH location, volume, or platelet counts between the groups. In-hospital mortality was lower in the moderate/severe group (23% vs 42%, p<0.0001). None/mild alcohol use was independently associated with more severe leukoaraiosis (p<0.0001) and higher case fatality (p<0.0001) compared to moderate/severe use in separate multivariable models.
Conclusion: Heavy alcohol use is strongly associated with an earlier ICH risk (median age difference of 13 years) and larger ICH volumes compared to none/mild alcohol use, relationships that might be explained by alcohol-related hypocoagulable state. Despite being much younger, heavy drinkers have similar cSVD burden compared to none/mild users. Moderate/severe alcohol consumption did not display clear negative effects on ICH- or cSVD-related characteristics or short-term outcomes.
  • Hindsholm, Mette  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Das, Alvin  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Rotschild, Ofer  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Gokcal, Elif  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Steven, Greenberg  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Rosand, Jonathan  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Goldstein, Joshua  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Gurol, Edip  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Mette Hindsholm: DO NOT have relevant financial relationships | Alvin Das: DO NOT have relevant financial relationships | Ofer Rotschild: DO NOT have relevant financial relationships | Elif Gokcal: DO NOT have relevant financial relationships | greenberg Steven: No Answer | Jonathan Rosand: No Answer | Joshua Goldstein: DO have relevant financial relationships ; Consultant:AstraZeneca:Active (exists now) ; Consultant:NControl:Past (completed) ; Consultant:Pfizer:Past (completed) ; Individual Stocks/Stock Options:Cayuga:Active (exists now) ; Consultant:Takeda:Active (exists now) ; Consultant:CSL Behring:Past (completed) ; Consultant:Octapharma:Active (exists now) | Edip Gurol: DO have relevant financial relationships ; Research Funding (PI or named investigator):AVID:Past (completed) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Past (completed)
Meeting Info:
Session Info:

Risk Factors and Prevention Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Excessive Alcohol Consumption and Heart Attack Risk

Schuver Trisha, Nwaneki Chisom, Ghimire Achala, Neupane Hemanta, Aderinwale Oluseyi, Sathiyaseelan Thiveya, Ukoha Nnenna, Annor Eugene, Obi Emeka, Karki Arpana, Ahuja Manik, Itopa Mercy, Osei Philomena

Clinical Outcomes of Patients with Alcoholic Cirrhosis and Acute STEMI Undergoing PCI

Alwarawrah Zaid, Alziadin Nmair, Alhalaseh Saleh, Odac Barbara, El Sharu Husam, Al Omar

More abstracts from these authors:
The Effects of Atrial Fibrillation Burden on Cognitive Function and Brain Structure

Rotschild Ofer, Le Brian, Gokcal Elif, Abramovitz Fouks Avia, Das Alvin, Greenberg Steven, Helmer Karl, Gurol Edip

Prognostic Value of Cortical Superficial Siderosis Among Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage

Das Alvin, Steven Greenberg, Gurol Edip, Abramovitz Fouks Avia, Gokcal Elif, Rotschild Ofer, Regenhardt Robert, Selim Magdy, Viswanathan Anand, Goldstein Joshua, Rosand Jonathan

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)